IV TXA Reduces Blood Loss and Transfusion Need in Intertrochanteric Fracture Surgery using PFNA
Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled TrialOrthop Surg. 2019 Aug;11(4):635-642.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
One hundred patients scheduled for surgical treatment of an intertrochanteric fracture with a proximal femoral nail anti-rotation system were randomized to receive tranexamic acid (TXA) or no treatment for the reduction of blood loss and need for transfusion. The primary outcome of interest was estimated total blood loss. Additional outcomes of interest included intra-operative and hidden blood lo...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE